Keywords
Risk Factors
Mortality
Intensive Care Units
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the epidemiological profile of patients with COVID-19 who progressed to more severe cases of the disease and required hospitalization in the Intensive Care Unit (ICU) of a hospital in Juiz de Fora - MG and to correlate such characteristics with the clinical outcome of the patient. Methods: This is an observational and cross-sectional study, in which medical records of patients with COVID-19 admitted to the ICU of a hospital in Juiz de Fora - MG, from April 2020 to October 2020 were analyzed. Results: Higher hospitalization rates were observed in males (62.7%) and the most frequently observed comorbidity was systemic arterial hypertension (67.3%). The chi-square test of independence showed that there is an association between death and the patient's age group. The presence of comorbidities did not prove to be a predictive factor for greater severity, since the ANOVA tests did not show statistically significant differences, with the sample size being an important limiting factor for this analysis. Conclusion: The highest risk of severe cases and deaths from COVID-19 was observed in elderly individuals, which enables the development of appropriate professional conduct for this specific group, preventing unfavorable outcomes.
References
APICELLA M, et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The Lancet Diabetes & Endocrinology, 2020; 9: 782-92.
BARBOSA IR, et al. Incidence of and mortality from COVID-19 in the older Brazilian population and its relationship with contextual indicators: an ecological study. Revista Brasileira de Geriatria e Gerontologia, 2020; 23(1): e 200171.
ESCOSTEGUY CC, et al. COVID-19: a cross-sectional study of suspected cases admitted to a federal hospital in Rio de Janeiro, Brazil, and factors associated with hospital death. Epidemiologia e Serviços de Saúde, 2021; 30(1): e2020750.
GALVÃO MHR e RONCALLI AG. Factors associated with increased risk of death from COVID-19: a survival analysis based on confirmed cases. Revista Brasileira de Epidemiologia. 2020; 23: e200106.
GENG J, et al. Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis. Frontiers in Medicine, 2021; 1 (8): 588013.
GOMES R, et al. Why do men use health services less than women? Explanations by men with low versus higher education. Caderno de Saúde Pública, 2007; 23(3): 565–74.
GUAN W, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal, 2020; 55(5): e2000547.
HUANG C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 2020; 395(10223): 497-506.
JAIN V e YUAN JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. International Journal of Public Health, 2020; 65: 533–46.
KUMAR A, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14(4): 535-45.
LI LQ, et al. COVID-19 patients clinical characteristics, discharge rate, and fatality rate of meta-analysis. Journal of Medical Virology, 2020; 92(6): 577-583.
LIU Y, et al. Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019. 2020.
PAIVA KM, et al. Prevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease. Arquivos Brasileiros de Cardiologia, 2021; 117(5): 968-975.
SIMONNET A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation. Obesity, 2020; 28(7): 1195–9.
TSANG HF, et al. An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies. Expert Review of Anti-infective Therapy., 2021; 19(7): 877-88.
WANG B, et al. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY), 2020; 12(7): 6049–57.
WU Z e MCGOOGAN JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA, 2020; 323(13): 1239.
YANBIN DU, et al. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. NMCD, 2021; 31(1): 745-755.
YANG J, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases, 2020; 94: 91–5.
ZHANG JJY, et al. Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis. Clinical Infectious Diseases, 2020; 71(16): 2199-206.